EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Global Perspectives on the Management of Periprosthetic Joint Infection

Nicolas S Piuzzi iD, Irene K Sigmund, Pablo A Slullitel, Nicolaas Budhiparama, Laurens Manning, Anabelle Visperas, Javad Parvizi

Journal of Bone and Joint Surgery · 19.11.2025 · 107 (22) · 2521-2528

DOI: 10.2106/jbjs.25.00775 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 19.11.2025. Verfasst von Nicolas S Piuzzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic, Cleveland, Ohio. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Joint Prosthesis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

➢ The rate of periprosthetic joint infection (PJI) is rising globally, with substantial regional variability, and PJI has 5-year mortality rates of 15% to 25%, which exceed those of early-stage breast and prostate cancer and rival those of colorectal and hematologic malignancies. ➢ Diagnostic criteria, including synovial fluid analysis, novel culture techniques, and molecular techniques, have improved in accuracy. However, infections caused by fastidious, biofilm-forming microorganisms continue to pose a major diagnostic challenge worldwide. ➢ While patient selection remains critical for successful outcomes, the use of DAIR (debridement, antibiotics, and implant retention), 1-stage, 2-stage, and 1.5-stage procedures varies across regions and is often influenced by logistical constraints, resource availability, and clinical expertise. In parallel, discordant definitions of treatment success in the literature hinder comparative research and outcome benchmarking. A tiered framework—encompassing infection eradication, surgical burden, joint function, and patient-reported outcomes—offers a path toward standardized and clinically meaningful reporting. ➢ Advances in immunogenetics, artificial intelligence-driven risk modeling, and precision medicine, alongside the emergence of research consortia and global collaborations, are opening new frontiers in treatment strategies and creating opportunities for innovative, individualized approaches to PJI management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsJoint ProsthesisHumansGlobal HealthDebridementAnti-Bacterial Agents

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Cleveland Clinic, Cleveland, Ohio.
  • Medical University of Vienna, Vienna, Austria.
  • Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • University of Airlangga, Surabaya, Indonesia.
  • Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • International Joint Center, Acibadem University Hospital, İstanbul, Turkey.

ORCID-Profile: Nicolas S Piuzzi

Zitieren

APA

Piuzzi, N. S., Sigmund, I. K., Slullitel, P. A., Budhiparama, N., Manning, L., Visperas, A., & Parvizi, J. (2025). Global Perspectives on the Management of Periprosthetic Joint Infection. Journal of Bone and Joint Surgery, 107(22), 2521-2528. https://doi.org/10.2106/jbjs.25.00775

Vancouver

Piuzzi NS, Sigmund IK, Slullitel PA, Budhiparama N, Manning L, Visperas A, et al. Global Perspectives on the Management of Periprosthetic Joint Infection. Journal of Bone and Joint Surgery. 2025;107(22):2521-2528. doi:10.2106/jbjs.25.00775

BibTeX
@article{Piuzzi2025,
  author = {Piuzzi, Nicolas S and Sigmund, Irene K and Slullitel, Pablo A and Budhiparama, Nicolaas and Manning, Laurens and Visperas, Anabelle and Parvizi, Javad},
  title = {Global Perspectives on the Management of Periprosthetic Joint Infection},
  journal = {Journal of Bone and Joint Surgery},
  year = {2025},
  volume = {107},
  number = {22},
  pages = {2521--2528},
  doi = {10.2106/jbjs.25.00775}
}
Kostenlos starten →